Novartis reported $2.23B in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 44.27B 22.58B
Astrazeneca AZN:US 539M 339M
Biogen BIIB:US $ -59.1M 669.8M
Bristol Myers Squibb BMY:US $ 2590M 37M
Canopy Growth Corp WEED:CN C$ -1838229000 1.3B
Catalent CTLT:US $ 246M 35M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Gilead Sciences GILD:US $ 2029M 1832M
Glaxosmithkline GSK:US $ 1081M 1720M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Horizon Pharma HZNP:US $ 88.56M 105.76M
Johnson & Johnson JNJ:US $ 5840M 22M
Lannett LCI:US $ -77.96M 55.88M
Merk MRK:US $ 4927M 642M
Novartis NOVN:VX 2.23B 624M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Perrigo Ordinary Shares PRGO:US $ -16.2M 37.9M
Pfizer PFE:US $ 12102M 2229M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Valeant Pharmaceuticals VRX:CN $ 352.69M 67.69M
Zoetis ZTS:US $ 670M 57M